Anti-D immunoglobulin is now widely used to prevent Rh-negative mothers from being sensitized by Rh-positive fetal erythrocytes. The administration of anti-D following the transfusion of large amounts of Rh-positive erythrocytes into Rh-negative individuals has been less uniformly successful in preventing primary immunization (Bowman and Chown, 1968) , and occasional mild (Woodrow et al, 1968) or severe (de Veber, 1968) 
Anti-D immunoglobulin is now widely used to prevent Rh-negative mothers from being sensitized by Rh-positive fetal erythrocytes. The administration of anti-D following the transfusion of large amounts of Rh-positive erythrocytes into Rh-negative individuals has been less uniformly successful in preventing primary immunization (Bowman and Chown, 1968) , and occasional mild (Woodrow et al, 1968) or severe (de Veber, 1968) reactions to plasma containing anti-D have been noted. The present case report demonstrates that while a large dose of anti-D immunoglobulin may be given with safety, a patient who is already weakly sensitized to the D antigen will subsequently show a rapid secondary immune response. Furthermore, a complication of unknown importance is the development of a positive direct anti-human globulin reaction on the patient's red cells; this reaction appearing 6 months after the immunoglobulin treatment.
Case History A 33-year-old multiparous housewife, blood group 0 Rh negative was admitted to the Casualty Department in a state of collapse. A diagnosis of haemorrhage from an ectopic pregnancy was made. At laparotomy a ruptured tubal pregnancy of approximately 6 weeks duration was found; the abdominal cavity containing about 2 litres of blood. During the operation the patient received 2 units of group 0 Rh-positive blood (approximately 400 ml of red cells) followed by 5 units of 0 Rhnegative blood. Her postoperative course was satisfactory and without gynaecological complication. An attempt to destroy the incompatible red cells by injection of anti-D immunoglobulin was considered advisable, as initial testing of the pretransfusion serum failed to reveal any irregular antibodies and the direct antiglobulin test was negative. When later repeat tests of the pre-transfusion serum revealed that the patient was in fact weakly sensitized to the D antigen, immunoglobulin therapy was stopped.
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The patient was seen at regular intervals for the subsequent 12 months. Eight months after the first ectopic pregnancy, intraperitoneal haemorrhage from a second ectopic pregnancy occurred and this again required emergency laparotomy.
Anti-D Therapy
Forty hours after the mismatched transfusion, the patient received 860 micrograms of anti-D immunoglobulin as a single intramuscular injection. During the next 5 days, pulse, temperature, and blood pressure were recorded every 4 hours. A fluid balance chart was maintained and the oral fluid intake kept above 3 1/24 hours. The subsequent dosage ofanti-D is illustrated in the Figure. The total dose over 96 hours was 6860 micrograms, and this was given as intramuscular injections of 860, 1200, 1400, 1400, and 2000 micrograms at 24-hour intervals. The clinical state was monitored closely after each injection. There was a slight increase in pulse rate and temperature 2-3 hours after each injection, but no other untoward effects were noted.
Before, during, and after the blood transfusion and subsequent to the anti-D therapy the following parameters were measured; haemoglobin, PCV, serum bilirubin, plasma haemoglobin, haptoglobin, a hyroxybutyrate dehydrogenase (aHBDH), the clearance of the D positive cells from the circulation, and the titre of anti-D.
Materials and Methods
Haemoglobin, PCV, serum bilirubin, plasma haemoglobin, and haptoglobin were all measured by standard methods (Dacie and Lewis, 1968) ; aHBDH estimation was performed by the method described by Wilkinson (1962) .* Anti-D immunoglobulin was obtained from the Lister Institute.t
Screening tests for irregular antibodies were performed by manual techniques using saline at 12°C and Judd and Jenkins (1970) .
Post-transfusion survival of Rh-positive cells was followed by using the automated Ashby differential agglutination techniques (Szymanski et al, 1967 LDH1 and LDH2 (Nutrition Reviews, 1966) , and it has been shown that in the absence of liver or muscle disease, axHBDH activity is mainly dependent on the concentration of these two anionic lactate dehydrogenase isosymes (Plummer et al, 1963 Mollison (1967) . The rare cases ofpost-transfusion thrombocytopenia may be due to a similar mechanism. Morrison and Mollison (1968) Six months later the patient developed a positive direct antiglobulin reaction which persisted for 3 months. The significance of the auto-antibody production and its relation to the previous immunoglobulin therapy is discussed.
